Endo Pharmaceuticals Inc., Lavipharm Laboratories Inc. deal

Endo acquired exclusive worldwide rights to Lavipharm’s Quick-Dis and transdermal drug delivery technologies for use in pain management. The companies will jointly formulate and develop products using...